This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient who has gout will begin taking febuxostat Uloric and colchicine. What will the nurse ... (Read 53 times)

Chloeellawright

  • Hero Member
  • *****
  • Posts: 588
on: Jul 23, 2018
A patient who has gout will begin taking febuxostat Uloric and colchicine. What will the nurse include when teaching this patient about this drug regimen?
 
  a. You are taking both drugs in order to prevent hepatic side effects.
  b. You may stop taking the febuxostat after your uric acid levels decrease.
  c. You will have to take both drugs indefi-nitely to treat your symptoms.
  d. You will stop taking the colchicine within 6 months after starting therapy.

Question 2

A hospitalized patient is being treated for tuberculosis with a drug regimen that includes pyrazinamide. The patient complains of pain in the knee and shoulder joints. The nurse will con-tact the provider to request an order for:
 
  a. ibuprofen.
  b. renal function tests.
  c. discontinuation of the pyrazinamide.
  d. measurement of uric acid levels.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

miss_1456@hotmail.com

  • Sr. Member
  • ****
  • Posts: 289
Reply #1 on: Jul 23, 2018
Answer to Question 1

D
At the beginning of therapy with fevuxostat, symptoms of gout may flare, so colchicine or NSAIDS are given for up to 6 months to alleviate this. The combination does not prevent effects on the liver. The febuxostat will be given indefinitely.

Answer to Question 2

A
Polyarthralgias occur in 40 of patients during the initial phase of treatment with pyrazinamide and can be managed with a nonsteroidal anti-inflammatory drug (NSAID). Renal function tests and uric acid levels are not indicated. Unless the pain cannot be managed with NSAIDs, there is no need to reduce the dose of pyrazinamide.


Chloeellawright

  • Member
  • Posts: 588
Reply 2 on: Jul 23, 2018
Wow, this really help

shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

« previous next »
 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Symptoms of a patient in shock. Symptoms of a patient in shock.
Patient teaching: female breast assessment Patient teaching: female breast assessment
Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ... Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ...
Colorimetric multiplex assay to determine anti-HLA antibodies in a patient's serum. Colorimetric multiplex assay to determine anti-HLA antibodies in a patient's serum.
Patient Physical Status Classification Patient Physical Status Classification
Video: Primary and secondary response to infection

For a complete list of videos, visit our video library